Table II.
Univariate analysis of prognostic factors and overall survival.
| Overall survival
|
|||
|---|---|---|---|
| Variable | n | Events | P-value |
| Age at diagnosis (years) | |||
| ≤65 | 92 | 35 | 0.122 |
| >65 | 35 | 18 | |
| Gender | |||
| Male | 82 | 33 | 0.708 |
| Female | 45 | 20 | |
| Tumor size (cm) | |||
| ≤5 | 86 | 25 | 0 |
| >5 | 41 | 28 | |
| T (depth of invasion) | |||
| 2 | 40 | 11 | 0.024 |
| 3 | 55 | 23 | |
| 4 | 32 | 19 | |
| N (lymph node metastasis) | |||
| 0 | 40 | 11 | 0.015 |
| 1 | 40 | 14 | |
| 2 | 28 | 16 | |
| 3 | 19 | 12 | |
| Differentiation | |||
| Differentiated | 14 | 10 | 0.022 |
| Undifferentiated | 113 | 43 | |
| Nuclear maspin immunoreactivity | |||
| Positive | 59 | 37 | 0 |
| Negative | 68 | 16 | |
| Cytoplasmic maspin immunoreactivity | |||
| Positive | 87 | 34 | 0.44 |
| Negative | 40 | 19 | |
Events, number of deaths during follow up.